Photodynamic therapy uses light-sensitive medicine and a special light source tdestroy cancerous or precancerous cells. This treatment limits damage tsurrounding healthy tissue. You’ll receive the photosensitizer by mouth, injection or through an IV, depending on the area being treated. Then the doctor exposes the area tspecial light.
Increasing incidence of cancer and skin disorders, minimally invasive treatment demand, and advancements in technology is anticipated tdrive growth of the global photodynamic therapy market over the forecast period. Moreover, favorable regulatory approvals is alsexpected tboost the growth of the global photodynamic therapy market over the forecast period. Personalized treatment approaches, collaboration with pharmaceutical companies, advancements in imaging techniques, and telemedicine and remote consultations are expected tcreate growth opportunities for the global photodynamic therapy market during the forecast period.
However, limited awareness and education, high treatment costs, and complex treatment protocols are expected thamper growth of the photodynamic therapy market over the forecast period.
- This report provides in-depth analysis of the global photodynamic therapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study alsprovides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global photodynamic therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Biofrontera AG, Theralase Technologies Inc., Photocure ASA, Quest PharmaTech Inc., Galderma S.A., DUSA Pharmaceuticals (a subsidiary of Sun Pharmaceutical Industries), Lumenis Ltd. (acquired by Bausch Health Companies Inc.), Biolitec AG, IPG Photonics Corporation, Boston Scientific Corporation, Asieris Meditech Co., Ltd., PDT Pharmaceuticals, Inc., Candela Corporation (a subsidiary of Syneron Medical Ltd.), Biolase, Inc., Photothera (now known as EpiCept Corporation)
- Insights from this report would allow marketers and the management authorities of the companies tmake informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global photodynamic therapy market report caters tvarious stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global photodynamic therapy market
-
- Cancer (Skin cancer, Lung cancer, Brain cancer, etc.)
- Dermatological Conditions (Acne, Psoriasis, Actinic Keratosis, etc.)
- Ophthalmology (Age-related Macular Degeneration, Retinal Diseases, etc.)
- Infectious Diseases (Fungal Infections, Bacterial Infections, etc.)
-
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
-
- Hematoporphyrin Derivative (HpD)
- Aminolevulinic Acid (ALA)
- Chlorins
- Porphyrins
- Phthalocyanines
-
- Oncology
- Dermatology
- Gastroenterology
- Gynecology
- Urology
-
- Topical PDT
- Systemic PDT
- Local PDT
-
- Laser Light
- Light Emitting Diodes (LEDs)
-
- Adult Patients
- Pediatric Patients
-
- Direct Sales
- Distributors
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Biofrontera AG
- Theralase Technologies Inc.
- Photocure ASA
- Quest PharmaTech Inc.
- Galderma S.A.
- DUSA Pharmaceuticals (a subsidiary of Sun Pharmaceutical Industries)
- Lumenis Ltd. (acquired by Bausch Health Companies Inc.)
- Biolitec AG
- IPG Photonics Corporation
- Boston Scientific Corporation
- Asieris Meditech Co., Ltd.
- PDT Pharmaceuticals, Inc.
- Candela Corporation (a subsidiary of Syneron Medical Ltd.)
- Biolase, Inc.
- Photothera (now known as EpiCept Corporation)
